Effects of interleukin 2 on cardiac function in the isolated rat heart (Q34260461)

1 August 2017

title

Effects of interleukin 2 on cardiac function in the isolated rat heart (English)

1 reference

1 August 2017

P A Sobotka

1

1 reference

1 August 2017

J McMannis

2

1 reference

1 August 2017

R I Fisher

3

1 reference

1 August 2017

D G Stein

4

1 reference

1 August 2017

J X Thomas

5

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 September 1990

1 reference

Journal of Clinical Investigation

1 August 2017

published in

1 reference

1 August 2017

volume

86

1 reference

1 August 2017

issue

3

1 reference

1 August 2017

page(s)

845-850

1 reference

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

1 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296801

Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296801

Blood-brain barrier dysfunction in cats following recombinant interleukin-2 infusion

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296801

Clinical effects and toxicity of interleukin-2 in patients with cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296801

The hemodynamic effects of treatment with interleukin-2 and lymphokine-activated killer cells

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296801

In vivo effects of recombinant IL-2. I. Isolation of circulating Leu-19+ lymphokine-activated killer effector cells from cancer patients receiving recombinant IL-2.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296801

Reversible cardiac dysfunction associated with interferon alfa therapy in AIDS patients with Kaposi's sarcoma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296801

Selective in Vitro Growth of T Lymphocytes from Normal Human Bone Marrows

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296801

Effect of pressure development on oxygen consumption by isolated rat heart

6 July 2018

1 reference

12 December 2020

Extravasation of intravascular fluid mediated by the systemic administration of recombinant interleukin 2

1 reference

12 December 2020

High-dose recombinant interleukin 2 in the treatment of patients with disseminated cancer. Responses, treatment-related morbidity, and histologic findings

1 reference

12 December 2020

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

1 reference

12 December 2020

Constant-infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer

1 reference

12 December 2020

Effects of interleukin-2 on renal function in patients receiving immunotherapy for advanced cancer

1 reference

12 December 2020

Increase of rat pulmonary microvascular permeability to albumin by recombinant interleukin-2

1 reference

12 December 2020

Metastatic renal cancer treated with interleukin-2 and lymphokine-activated killer cells. A phase II clinical trial

1 reference

12 December 2020

Recombinant alpha 2 interferon-related cardiomyopathy

1 reference

12 December 2020

Identifiers

DOI

10.1172/JCI114783

1 reference

1 August 2017

1 reference

1 August 2017

1 reference